Cellectar Biosciences CLRB
NASDAQ CLRB
$1.78 -0.09 (-4.81%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cellectar Biosciences (CLRB) Sales of Property, Plant and Equipment (2018)

Updated

Cellectar Biosciences' Sales of Property, Plant and Equipment came in at $10,000 for Q4 2018.

Analysis

Cellectar Biosciences (CLRB) Sales of Property, Plant and Equipment (2018) Analysis & Trends

For FY2018, Cellectar Biosciences' Sales of Property, Plant and Equipment was $55,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Cellectar Biosciences 21.77 Mn 21.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 10,000.00
API Access

Cellectar Biosciences Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=CLRB&period=max&api_key=YOUR_API_KEY